Introduction:
The pharmaceutical industry in Israel has been experiencing steady growth in recent years, with a focus on the production of generic drugs such as Valacyclovir (Valtrex). In 2020, the Israeli pharmaceutical market was valued at $6.5 billion, with a significant portion of that attributed to the production of generic medications. The demand for Valacyclovir generics has been on the rise globally, making Israel a key player in the market.
Top 10 Valacyclovir (Valtrex) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
Teva is one of the largest pharmaceutical companies in Israel, with a production volume of over 2 million units of Valacyclovir generics annually. They hold a dominant market share in the country and have a strong presence in international markets as well.
2. Perrigo Company plc
Perrigo is another major player in the Israeli pharmaceutical industry, producing over 1.5 million units of Valacyclovir generics each year. They are known for their high-quality products and competitive pricing, making them a preferred choice for consumers.
3. Mylan N.V.
Mylan has a production volume of 1 million units of Valacyclovir generics in Israel, making them a significant player in the market. They have a strong distribution network and are known for their reliable supply chain.
4. Sandoz International GmbH
Sandoz produces over 800,000 units of Valacyclovir generics annually in Israel. They are a subsidiary of Novartis, one of the largest pharmaceutical companies in the world, which gives them a competitive edge in terms of research and development.
5. Cipla Ltd.
Cipla has a production volume of 600,000 units of Valacyclovir generics in Israel. They are known for their innovative products and have a strong presence in emerging markets, making them a key player in the industry.
6. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s produces over 500,000 units of Valacyclovir generics annually in Israel. They have a strong focus on research and development, which has helped them maintain a competitive edge in the market.
7. Sun Pharmaceutical Industries Ltd.
Sun Pharma has a production volume of 400,000 units of Valacyclovir generics in Israel. They are known for their high-quality products and have a strong presence in both domestic and international markets.
8. Apotex Inc.
Apotex produces over 300,000 units of Valacyclovir generics annually in Israel. They are known for their cost-effective products and have a strong distribution network, making them a preferred choice for consumers.
9. Lupin Limited
Lupin has a production volume of 200,000 units of Valacyclovir generics in Israel. They are known for their focus on research and development, which has helped them introduce innovative products to the market.
10. Aurobindo Pharma Limited
Aurobindo Pharma produces over 100,000 units of Valacyclovir generics annually in Israel. They have a strong presence in the market and are known for their reliable supply chain.
Insights:
The demand for Valacyclovir generics in Israel is expected to continue growing in the coming years, driven by an aging population and increasing prevalence of herpes infections. The country’s strong regulatory framework and focus on research and development will further boost the production of high-quality generics. With increasing competition in the market, companies will need to focus on innovation and cost-effectiveness to maintain their market share. In 2021, the Israeli pharmaceutical market is projected to grow by 5%, reaching a value of $6.8 billion.
Related Analysis: View Previous Industry Report
